chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Patient arrived to our ED in Cardiac Arrest. Did not survive.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Chest pain, Costochondritis, Electrocardiogram
Clinical narrative: Experienced chest pain on patient left side from 11/22-11/28/21.  Visited ER on 11/28/21 and was diagnosed with costochondritis, treated with advil and rest.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory abnormal, Palpitations, Supraventricular extrasystoles, Tachycardia, Ventricular extrasystoles
Clinical narrative: Heart palpitations, tachycardia. Holter monitor resulted PVC's and PAC's and tachycardia. Started on beta blocker.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Vaccine administered at half dose.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received Covid vaccine number 2 before we confirmed date of Covid number 1 dose provided at an outside resource.  Covid number 1 was provided on 11/17/21 which was only 16 days prior to covid number 2 dose.  CDC recommendations reviewed and noted that dosing under 17 days apart require a readministration of covid number 2 dose 3 weeks after erroneous dose.  Parent of child called and made aware of this event and she voiced understanding .  Note placed in chart to offer a readministration of dosing for covid number 2.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: PATIENT WAS GIVEN 0.2ML OF THE 30MCG FORMULA INSTEAD OF 0.2ML OF THE 10MCG FORUMLA
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Headache, Nausea, Pyrexia
Clinical narrative: Fever to 101.5, dry cough, difficulty breathing, headache and nausea.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection site pain/swelling/redness, fever, headache, fatigue, muscle pain, joint pain.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Injection site pain/swelling/redness, fever, headache, fatigue, muscle pain, joint pain.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, Asthenia, Blood creatinine increased, Blood urea increased
Clinical narrative: Fully vaccinated patient who admitted through ED for ongoing nausea and vomitting.  Provider discharge note below:  "Per HPI, a 70 YO female with past medical history of GERD, HLD, HTN presenting to Hospital with from ED with complaints of generalized weakness and diarrhea that began 2 weeks ago, she came to the ED and was tested for COVID-19 on 10/31/21 and results were positive. Per daughter the patient has been nauseous and unable to eat or drink much. She is able to take her blood pressure medication and ""keep it down."" However, her symptoms have been progressing and this week she developed non-bloody vomiting and blurry vision. She denies noticing any blood in her stool. Today she endorses feeling weak and having abdominal pain. She denies chest pain, shortness of breath, headache, dizziness, fevers, chills or diaphoresis.    At ED her vitals were stable but her labs came back for significant values for extremely elevated Cr 15.7, BUN 131, hyperkalemia 5.6, proteinuria and leukocytosis. She was given 2L of NS. She was transferred to Ed for evaluation and possible emergent dialysis.    Nephrology was consulted and she was admitted under our services for management of all her chronic conditions. She received zofran for nausea and had one episode of brown colored emesis in the ED. She was also started on more fluids here. Chest xray and CT head was negative for any acute process. EKG negative for any acute changes.    Hospital Course:  1. AKI: likely due to ATN from volume loss. Improving with good UOP. S/p HD 11/5, 11/6 with significant improvement. No indication for further HD, access discontinued. Follow up with nephrology as an outpatient    2. COVID-19: patient afebrile, maintaining adequate saturation on RA. Having diarrhea, improved   3. HTN - Restarted lisinopril - Holding HCTZ for now.   4. Sinus bradycardia: asymptomatic - Hold metoprolol for now   5. Normocytic anemia: stable "
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram head normal, Condition aggravated, Diarrhoea
Clinical narrative: Fully vaccinated patient who admitted through ED for ongoing nausea and vomitting.  Provider discharge note below:  "Per HPI, a 70 YO female with past medical history of GERD, HLD, HTN presenting to Hospital with from ED with complaints of generalized weakness and diarrhea that began 2 weeks ago, she came to the ED and was tested for COVID-19 on 10/31/21 and results were positive. Per daughter the patient has been nauseous and unable to eat or drink much. She is able to take her blood pressure medication and ""keep it down."" However, her symptoms have been progressing and this week she developed non-bloody vomiting and blurry vision. She denies noticing any blood in her stool. Today she endorses feeling weak and having abdominal pain. She denies chest pain, shortness of breath, headache, dizziness, fevers, chills or diaphoresis.    At ED her vitals were stable but her labs came back for significant values for extremely elevated Cr 15.7, BUN 131, hyperkalemia 5.6, proteinuria and leukocytosis. She was given 2L of NS. She was transferred to Ed for evaluation and possible emergent dialysis.    Nephrology was consulted and she was admitted under our services for management of all her chronic conditions. She received zofran for nausea and had one episode of brown colored emesis in the ED. She was also started on more fluids here. Chest xray and CT head was negative for any acute process. EKG negative for any acute changes.    Hospital Course:  1. AKI: likely due to ATN from volume loss. Improving with good UOP. S/p HD 11/5, 11/6 with significant improvement. No indication for further HD, access discontinued. Follow up with nephrology as an outpatient    2. COVID-19: patient afebrile, maintaining adequate saturation on RA. Having diarrhea, improved   3. HTN - Restarted lisinopril - Holding HCTZ for now.   4. Sinus bradycardia: asymptomatic - Hold metoprolol for now   5. Normocytic anemia: stable "
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Feeding disorder, Hyperkalaemia, Hypertension, Leukocytosis
Clinical narrative: Fully vaccinated patient who admitted through ED for ongoing nausea and vomitting.  Provider discharge note below:  "Per HPI, a 70 YO female with past medical history of GERD, HLD, HTN presenting to Hospital with from ED with complaints of generalized weakness and diarrhea that began 2 weeks ago, she came to the ED and was tested for COVID-19 on 10/31/21 and results were positive. Per daughter the patient has been nauseous and unable to eat or drink much. She is able to take her blood pressure medication and ""keep it down."" However, her symptoms have been progressing and this week she developed non-bloody vomiting and blurry vision. She denies noticing any blood in her stool. Today she endorses feeling weak and having abdominal pain. She denies chest pain, shortness of breath, headache, dizziness, fevers, chills or diaphoresis.    At ED her vitals were stable but her labs came back for significant values for extremely elevated Cr 15.7, BUN 131, hyperkalemia 5.6, proteinuria and leukocytosis. She was given 2L of NS. She was transferred to Ed for evaluation and possible emergent dialysis.    Nephrology was consulted and she was admitted under our services for management of all her chronic conditions. She received zofran for nausea and had one episode of brown colored emesis in the ED. She was also started on more fluids here. Chest xray and CT head was negative for any acute process. EKG negative for any acute changes.    Hospital Course:  1. AKI: likely due to ATN from volume loss. Improving with good UOP. S/p HD 11/5, 11/6 with significant improvement. No indication for further HD, access discontinued. Follow up with nephrology as an outpatient    2. COVID-19: patient afebrile, maintaining adequate saturation on RA. Having diarrhea, improved   3. HTN - Restarted lisinopril - Holding HCTZ for now.   4. Sinus bradycardia: asymptomatic - Hold metoprolol for now   5. Normocytic anemia: stable "
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Normocytic anaemia, Proteinuria, Renal tubular necrosis, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated patient who admitted through ED for ongoing nausea and vomitting.  Provider discharge note below:  "Per HPI, a 70 YO female with past medical history of GERD, HLD, HTN presenting to Hospital with from ED with complaints of generalized weakness and diarrhea that began 2 weeks ago, she came to the ED and was tested for COVID-19 on 10/31/21 and results were positive. Per daughter the patient has been nauseous and unable to eat or drink much. She is able to take her blood pressure medication and ""keep it down."" However, her symptoms have been progressing and this week she developed non-bloody vomiting and blurry vision. She denies noticing any blood in her stool. Today she endorses feeling weak and having abdominal pain. She denies chest pain, shortness of breath, headache, dizziness, fevers, chills or diaphoresis.    At ED her vitals were stable but her labs came back for significant values for extremely elevated Cr 15.7, BUN 131, hyperkalemia 5.6, proteinuria and leukocytosis. She was given 2L of NS. She was transferred to Ed for evaluation and possible emergent dialysis.    Nephrology was consulted and she was admitted under our services for management of all her chronic conditions. She received zofran for nausea and had one episode of brown colored emesis in the ED. She was also started on more fluids here. Chest xray and CT head was negative for any acute process. EKG negative for any acute changes.    Hospital Course:  1. AKI: likely due to ATN from volume loss. Improving with good UOP. S/p HD 11/5, 11/6 with significant improvement. No indication for further HD, access discontinued. Follow up with nephrology as an outpatient    2. COVID-19: patient afebrile, maintaining adequate saturation on RA. Having diarrhea, improved   3. HTN - Restarted lisinopril - Holding HCTZ for now.   4. Sinus bradycardia: asymptomatic - Hold metoprolol for now   5. Normocytic anemia: stable "
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus bradycardia, Vision blurred, Vomiting
Clinical narrative: Fully vaccinated patient who admitted through ED for ongoing nausea and vomitting.  Provider discharge note below:  "Per HPI, a 70 YO female with past medical history of GERD, HLD, HTN presenting to Hospital with from ED with complaints of generalized weakness and diarrhea that began 2 weeks ago, she came to the ED and was tested for COVID-19 on 10/31/21 and results were positive. Per daughter the patient has been nauseous and unable to eat or drink much. She is able to take her blood pressure medication and ""keep it down."" However, her symptoms have been progressing and this week she developed non-bloody vomiting and blurry vision. She denies noticing any blood in her stool. Today she endorses feeling weak and having abdominal pain. She denies chest pain, shortness of breath, headache, dizziness, fevers, chills or diaphoresis.    At ED her vitals were stable but her labs came back for significant values for extremely elevated Cr 15.7, BUN 131, hyperkalemia 5.6, proteinuria and leukocytosis. She was given 2L of NS. She was transferred to Ed for evaluation and possible emergent dialysis.    Nephrology was consulted and she was admitted under our services for management of all her chronic conditions. She received zofran for nausea and had one episode of brown colored emesis in the ED. She was also started on more fluids here. Chest xray and CT head was negative for any acute process. EKG negative for any acute changes.    Hospital Course:  1. AKI: likely due to ATN from volume loss. Improving with good UOP. S/p HD 11/5, 11/6 with significant improvement. No indication for further HD, access discontinued. Follow up with nephrology as an outpatient    2. COVID-19: patient afebrile, maintaining adequate saturation on RA. Having diarrhea, improved   3. HTN - Restarted lisinopril - Holding HCTZ for now.   4. Sinus bradycardia: asymptomatic - Hold metoprolol for now   5. Normocytic anemia: stable "
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicectomy, Appendicitis, Blood test, Computerised tomogram, Headache
Clinical narrative: Appendicitis resulting in appendectomy. Patient had nonstop vomiting for 2 days, nausea, lethargy, headache that started hours after the 2nd dose.  She was feeling great and healthy prior to the shot.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Nausea, Vomiting
Clinical narrative: Appendicitis resulting in appendectomy. Patient had nonstop vomiting for 2 days, nausea, lethargy, headache that started hours after the 2nd dose.  She was feeling great and healthy prior to the shot.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: The day after the vaccine, a lymph node under my right jaw became swollen enough to result in shooting pain. The swelling and pain gradually reduced in severity over the next several days, but the lymph node remained swollen to some degree for the next month.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Feeling hot, Hyperhidrosis, Hypoaesthesia
Clinical narrative: pt came back to pharmacy within 15 minutes to complain of racing heart, difficulties breathing, sweating, feeling hot, right sided facial numbness, and dizziness.  EMS called to evaluate pt. pt and husband state she has issues with anxiety and these events feel similar to a panic attack/anxiety.  Pt given water. EMS determined pt stable and pt chose not to leave with EMS for further evaluation. Pt remained in consultation room for 5 minutes after EMS left and left with her husband when she felt ready.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: pt came back to pharmacy within 15 minutes to complain of racing heart, difficulties breathing, sweating, feeling hot, right sided facial numbness, and dizziness.  EMS called to evaluate pt. pt and husband state she has issues with anxiety and these events feel similar to a panic attack/anxiety.  Pt given water. EMS determined pt stable and pt chose not to leave with EMS for further evaluation. Pt remained in consultation room for 5 minutes after EMS left and left with her husband when she felt ready.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received Covid vaccine number 2 before we confirmed date of Covid number 1 dose provided at an outside resource.  Covid number 1 was provided on 11/17/21 which was only 16 days prior to covid number 2 dose.  CDC recommendations reviewed and noted that dosing under 17 days apart require a readministration of covid number 2 dose 3 weeks after erroneous dose.  Parent of child called and made aware of this event and she voiced understanding .  Note placed in chart to offer a readministration of dosing for covid number 2.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Gave 0.5 ml dose vs. 0.25 ml during clinic
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: I had vertigo and my ENT prescribed meclizine which helped the symptoms and they were gone after 2 days
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Paranasal sinus discomfort, Respiratory tract congestion, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: I had a weeks worth of worsening congestion and cough when I went in and lots of sinus pressure and green mucus. I was given Augmentin to treat.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Neuropathy peripheral, Paraesthesia
Clinical narrative: Shingrix dose 1 of 2 received 8/16/21.  Patient reports experiencing 4-5/10 epidermis-level, neuropathy-like neck pain/paresthesia at base of skull lasting for 1 day, about 3 days after administration of dose 1. Resolved within a day without intervention or recurrence. Patient states was able to continue and complete ADLs during that day.  Patient consents to receive today's dose 2 of 2. Advised patient to contact PCP if this reaction happens again.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Vaccine administered at half dose.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Skin test, Urticaria
Clinical narrative: Had a persisting outbreak of hives starting on 11/1. Had to go to urgent care to get steroid shot and antihistamines. Still continuing to this day 12/7 just not as bad.
Age: 10.0
Sex: U
Vaccine: COVID19
Symptoms: Immunisation, Syringe issue
Clinical narrative: Needle malfunction, vaccine leaked out-was revaccinated
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram, Anticoagulant therapy, Atrial fibrillation, Bradycardia
Clinical narrative: Fully vaccinated patient admitted through ED for COVID-19. Provider D/C note below:  "81-year-old male patient with past medical history of obesity, hypertension, diabetes mellitus type 2   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Treated  For covid 19    Started on Eliquis for AFib  Eliquis stopped on the advice of Cardiology, also she stopped remdesivir due to bradycardia   Acute hypoxic respiratory failure due to COVID-19 infection /pneumonia CTA has ruled out PE, on remdesivir and steroids   Atrial fibrillaton -was found to be in AFib on the night of 11/8, converted back to sinus rhythm, echo showed LVEF of 60%, grade 2 diastolic dysfunction,  started on anticoagulation ChDVASC of 4   was on Eliquis, 11/1.  On the advice of Cardiology cause of isolated event of AFib   Bradycardia-with episodes most likely related to remdesivir, which has been discontinued  11/12 continues to be bradycardic often in 40s his, asymptomatic Planned discharge was  Postponed, , after discussing with cardiologist since heart is improved patient was discharged Cellulitis of the right leg- on Ancef from 11/8, improving "
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardioversion, Cellulitis, Diastolic dysfunction
Clinical narrative: Fully vaccinated patient admitted through ED for COVID-19. Provider D/C note below:  "81-year-old male patient with past medical history of obesity, hypertension, diabetes mellitus type 2   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Treated  For covid 19    Started on Eliquis for AFib  Eliquis stopped on the advice of Cardiology, also she stopped remdesivir due to bradycardia   Acute hypoxic respiratory failure due to COVID-19 infection /pneumonia CTA has ruled out PE, on remdesivir and steroids   Atrial fibrillaton -was found to be in AFib on the night of 11/8, converted back to sinus rhythm, echo showed LVEF of 60%, grade 2 diastolic dysfunction,  started on anticoagulation ChDVASC of 4   was on Eliquis, 11/1.  On the advice of Cardiology cause of isolated event of AFib   Bradycardia-with episodes most likely related to remdesivir, which has been discontinued  11/12 continues to be bradycardic often in 40s his, asymptomatic Planned discharge was  Postponed, , after discussing with cardiologist since heart is improved patient was discharged Cellulitis of the right leg- on Ancef from 11/8, improving "
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated patient admitted through ED for COVID-19. Provider D/C note below:  "81-year-old male patient with past medical history of obesity, hypertension, diabetes mellitus type 2   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Treated  For covid 19    Started on Eliquis for AFib  Eliquis stopped on the advice of Cardiology, also she stopped remdesivir due to bradycardia   Acute hypoxic respiratory failure due to COVID-19 infection /pneumonia CTA has ruled out PE, on remdesivir and steroids   Atrial fibrillaton -was found to be in AFib on the night of 11/8, converted back to sinus rhythm, echo showed LVEF of 60%, grade 2 diastolic dysfunction,  started on anticoagulation ChDVASC of 4   was on Eliquis, 11/1.  On the advice of Cardiology cause of isolated event of AFib   Bradycardia-with episodes most likely related to remdesivir, which has been discontinued  11/12 continues to be bradycardic often in 40s his, asymptomatic Planned discharge was  Postponed, , after discussing with cardiologist since heart is improved patient was discharged Cellulitis of the right leg- on Ancef from 11/8, improving "
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Diarrhoea, Headache, Nasal congestion, Nausea
Clinical narrative: nausea and diarrhea, cough, congestion, body aches, headache starting on 11/30/21
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain
Clinical narrative: nausea and diarrhea, cough, congestion, body aches, headache starting on 11/30/21
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Vaccine administered at half dose.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Gave 0.5 ml dose vs. 0.25ml dose
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Chest pain, Drooling, Dysarthria, Oxygen saturation decreased
Clinical narrative: Female patient age 44, at the time of vaccination, no PMH was mentioned. Patient was her daughtrer. After receiving the vaccine dose at 10:05, patient being waving her hands and yelled for help at 10:12. Clinician went over to waiting area about ten feet away from the vaccination are. Patient began shaking, drooling, and was unable to speak. This continued for 4 minutes until 10:16. 911 was called and clinician was put on hold. Patient had slurred speech and was able to shake her head to answer yes or no questions to conduct a quick assessment. Patient's daughter stated that patient has a history of of seziures in the past, but was unaware of her last experience. Pulse ox was noted to be at 95%. (continued)
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Female patient age 44, at the time of vaccination, no PMH was mentioned. Patient was her daughtrer. After receiving the vaccine dose at 10:05, patient being waving her hands and yelled for help at 10:12. Clinician went over to waiting area about ten feet away from the vaccination are. Patient began shaking, drooling, and was unable to speak. This continued for 4 minutes until 10:16. 911 was called and clinician was put on hold. Patient had slurred speech and was able to shake her head to answer yes or no questions to conduct a quick assessment. Patient's daughter stated that patient has a history of of seziures in the past, but was unaware of her last experience. Pulse ox was noted to be at 95%. (continued)
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Blood culture, Blood fibrinogen, C-reactive protein increased
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Coagulation test, Cough, Culture throat, Culture urine
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer, Full blood count normal, Immunology test, International normalised ratio, Laboratory test
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test normal, Mobility decreased, Neck pain, Pain in extremity, Periorbital swelling
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Prothrombin time, Rash, Red blood cell sedimentation rate, Swelling face, Urine analysis
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Mom states that 5 days ago (11/30), patient woke up with hives-like rash, gave Benadryl. The following day, rash remained persistent, patient also woke up with puffy eyes and appeared to have facial swelling. Took patient to the pediatrician and allergist, where she received epi x1 and prescribed prednisone (3 day course) and zyrtec. Patient was feeling well  on 12/2-12/3, but on 12/4, patient started to complain more of joint pain, mostly complaining of pain in her neck, back, thighs, and feet, and became less mobile (refusing to get off the couch). Mom notes steroids initially seemed to help with the rash (seemed more flat than previously), but then after the first day of steroids rash worsened again and patient had possibly worsening facial swelling. During hospitalization the rash subsided and a dry cough developed. Albuterol was used to alleviate the cough and was discharged (12/7) on flovent, nasonex, and albuterol.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Fatigue, Feeling abnormal, Pain
Clinical narrative: 100.8 Fahrenheit fever, chills, palpitations, bones aching in a throbbing manner, fatigue, brain fog
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia
Clinical narrative: 100.8 Fahrenheit fever, chills, palpitations, bones aching in a throbbing manner, fatigue, brain fog
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore arm night of, then fever starting at 11 am and muscle aches
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site erythema, Injection site swelling, Limb discomfort, Nodule
Clinical narrative: Pt called Pharmacy on 12/07/2021 and reported adverse reaction to Pfizer vaccine that she received on 12/02/2021. Pt reported, swelling, redness spreading up to 4x5 inches around injection site, fever for 3 days. Arm is still bruised, swollen, knotty. Pt can touch and feel but cannot press the arm. Pt reported throbbing pain in the injection arm.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling, Pyrexia, Vaccination complication
Clinical narrative: Pt called Pharmacy on 12/07/2021 and reported adverse reaction to Pfizer vaccine that she received on 12/02/2021. Pt reported, swelling, redness spreading up to 4x5 inches around injection site, fever for 3 days. Arm is still bruised, swollen, knotty. Pt can touch and feel but cannot press the arm. Pt reported throbbing pain in the injection arm.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Gave 0.5 ml dose vs. 0.25 ml dose during clinic
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site vesicles
Clinical narrative: Raised blister-like reaction approximately 1cm away from the injection site and under the bandaid.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bronchiectasis, COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Fully vaccinated patient admitted through ED for increasing shortness of breath found to be COVID positive.  Provider discharge note below:    Patient was hospitalized with increasing SOB found to have covid pneumonia. She was placed on a covid protocol, including ,regeneron infusion,  on admission of a 5 day steroid + remdesivir daily infusion. She has comorbidity of COPD on chronic oxygen she was quite stable requiring 2-3 liters NC oxygen which is her home level. She was found to have desaturations prn with activity normalizing with rest. She has chronic bronchiectasis and was maintained on mucinex in the hospital. On the day of discharge she was clinically stable, AO, up to the bathroom, eating well with baseline pulmonary exam of chronic mild wheezing and rhonchi. She is discharged home to a family situation of non vaccinated individuals they are planning on risk modification. ( masks, wipes, isolating) She is placed on a tapering prednisone protocol in view of her recent prolonged steroid use. "
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Multimorbidity, Oxygen saturation decreased, Rhonchi, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated patient admitted through ED for increasing shortness of breath found to be COVID positive.  Provider discharge note below:    Patient was hospitalized with increasing SOB found to have covid pneumonia. She was placed on a covid protocol, including ,regeneron infusion,  on admission of a 5 day steroid + remdesivir daily infusion. She has comorbidity of COPD on chronic oxygen she was quite stable requiring 2-3 liters NC oxygen which is her home level. She was found to have desaturations prn with activity normalizing with rest. She has chronic bronchiectasis and was maintained on mucinex in the hospital. On the day of discharge she was clinically stable, AO, up to the bathroom, eating well with baseline pulmonary exam of chronic mild wheezing and rhonchi. She is discharged home to a family situation of non vaccinated individuals they are planning on risk modification. ( masks, wipes, isolating) She is placed on a tapering prednisone protocol in view of her recent prolonged steroid use. "
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Fully vaccinated patient admitted through ED for increasing shortness of breath found to be COVID positive.  Provider discharge note below:    Patient was hospitalized with increasing SOB found to have covid pneumonia. She was placed on a covid protocol, including ,regeneron infusion,  on admission of a 5 day steroid + remdesivir daily infusion. She has comorbidity of COPD on chronic oxygen she was quite stable requiring 2-3 liters NC oxygen which is her home level. She was found to have desaturations prn with activity normalizing with rest. She has chronic bronchiectasis and was maintained on mucinex in the hospital. On the day of discharge she was clinically stable, AO, up to the bathroom, eating well with baseline pulmonary exam of chronic mild wheezing and rhonchi. She is discharged home to a family situation of non vaccinated individuals they are planning on risk modification. ( masks, wipes, isolating) She is placed on a tapering prednisone protocol in view of her recent prolonged steroid use. "
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Vaccine administered at half dose.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pallor, Syncope, Vomiting
Clinical narrative: about 10 minutes after the patient received the vaccine she fainted. Mom is not sure if there were any convulsions or not. When she came to she was very nauseated and started vomiting. She became very pale and felt very faint again. She had to keep her head between her legs to keep from fainting. We called the paramedics and they took over caring for the patient.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Magnetic resonance imaging, Scan
Clinical narrative: None stated.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Laboratory test, Ocular hyperaemia, Oedema peripheral, Pruritus
Clinical narrative: under arms were like sun burnt itchy sore to touch swollen and red ring around areas.  moved down to lower left arm.  moved to right arm and left eye.  all over my waist and inside upper legs.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: under arms were like sun burnt itchy sore to touch swollen and red ring around areas.  moved down to lower left arm.  moved to right arm and left eye.  all over my waist and inside upper legs.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Dyspnoea, Fatigue, Influenza like illness
Clinical narrative: Patient has flu-like symptoms with myalgia, fatigue, chills, chest tightness, SOB x 1 week. Patient is getting better after natural treatments.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, SARS-CoV-2 test positive
Clinical narrative: Patient has flu-like symptoms with myalgia, fatigue, chills, chest tightness, SOB x 1 week. Patient is getting better after natural treatments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Discussed possible side effects with pt which would likely be similar to 2nd dose.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Dyspnoea, Malaise, Oropharyngeal pain
Clinical narrative: Viral syndrome of rhinorrhea, sore throat, decreased appetite, malaise, increased dyspnea
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Viral infection
Clinical narrative: Viral syndrome of rhinorrhea, sore throat, decreased appetite, malaise, increased dyspnea
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram normal, Electrocardiogram normal, Electroencephalogram normal, Laboratory test, Seizure
Clinical narrative: Seizure in a person who had never had a seizure before. Healthcare provider/pediatric neurology could not identify reason for seizure.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Vaccine administered at half dose.
Age: 17.0
Sex: M
Vaccine: HEPA, HPV9, MENB, MNQ
Symptoms: Dizziness, Feeling hot, Heart rate decreased, Hyperhidrosis, Immediate post-injection reaction
Clinical narrative: IMMEDIATELY AFTER VACCINATIONS INCLUDING HPV,MENINGITIS B, MENINGITIS A, HEP A.HE FELT LIGHT HEADED,S, HE WAS SWEATY,HOT, PULSE NOT EASILY PALPALPA BLE  HEART RATE LOW. HE LAID FLAT ON THE EXAM COUCH, BP AT 1505PM 67/32 HR 40. DRANK WATER, VOMITED. REPEAT BP AT 1520 WAS 112/72 LYING DOWN HR 79. HE FELT MUCH BETTER. WAS SITTING UP HAVING CONVERSATIONS. PULSE EASILY PALPABLE OF GOOD RATE AND VOLUME. REPEAT BP AT 1535PM WAS 110/67 HR 63. REPEAT BP AT 1550PM 109/62 HR 63.
Age: 17.0
Sex: M
Vaccine: HEPA, HPV9, MENB, MNQ
Symptoms: Vomiting
Clinical narrative: IMMEDIATELY AFTER VACCINATIONS INCLUDING HPV,MENINGITIS B, MENINGITIS A, HEP A.HE FELT LIGHT HEADED,S, HE WAS SWEATY,HOT, PULSE NOT EASILY PALPALPA BLE  HEART RATE LOW. HE LAID FLAT ON THE EXAM COUCH, BP AT 1505PM 67/32 HR 40. DRANK WATER, VOMITED. REPEAT BP AT 1520 WAS 112/72 LYING DOWN HR 79. HE FELT MUCH BETTER. WAS SITTING UP HAVING CONVERSATIONS. PULSE EASILY PALPABLE OF GOOD RATE AND VOLUME. REPEAT BP AT 1535PM WAS 110/67 HR 63. REPEAT BP AT 1550PM 109/62 HR 63.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Inflammatory marker increased, Mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: Woke up the 16th with a sore thumb. A couple days later my whole hand was sore and swelling began that Saturday. I've went to many different doctors. They said it was tendinitis then it was De Quervain's tenosynovitis from having a new baby. I started therapy today because I can't move my fingers, hand or wrist. He immediately said it was not either of those diagnoses. He thinks it's an inflammatory response to the vaccine. My inflammatory markers were sky high when they drew labs last.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Tendonitis, Tenosynovitis stenosans, X-ray limb normal
Clinical narrative: Woke up the 16th with a sore thumb. A couple days later my whole hand was sore and swelling began that Saturday. I've went to many different doctors. They said it was tendinitis then it was De Quervain's tenosynovitis from having a new baby. I started therapy today because I can't move my fingers, hand or wrist. He immediately said it was not either of those diagnoses. He thinks it's an inflammatory response to the vaccine. My inflammatory markers were sky high when they drew labs last.
Age: 100.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acute myocardial infarction, Agonal respiration, COVID-19, Culture urine positive
Clinical narrative: Fully vaccinated patient who admitted with positive COVID test.  Provider discharge note below:    "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."
Age: 100.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Electrocardiogram abnormal, Hypertensive crisis, Hypoxia, Klebsiella test positive
Clinical narrative: Fully vaccinated patient who admitted with positive COVID test.  Provider discharge note below:    "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."
Age: 100.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Leukopenia, Pain, SARS-CoV-2 test positive, Tachycardia, Troponin increased
Clinical narrative: Fully vaccinated patient who admitted with positive COVID test.  Provider discharge note below:    "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."
Age: 100.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary tract infection, Urine analysis abnormal
Clinical narrative: Fully vaccinated patient who admitted with positive COVID test.  Provider discharge note below:    "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient got pfizer dose 1,2 on 3/24 and 6/11.  Patient was not due for 3rd dose until 12/11 and got dose on 12/7. No adverse reactions so far
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells palsy symptoms starting on the evening of 12/4, presented to ED on 12/7. Giving steroids as treatment
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Computerised tomogram head, Dizziness, Electrocardiogram
Clinical narrative: dizzy, weak and having headache,  elevated blood pressures - hypertensive urgency/emergency - required urgent care and then ER evaluation.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertensive urgency, Laboratory test
Clinical narrative: dizzy, weak and having headache,  elevated blood pressures - hypertensive urgency/emergency - required urgent care and then ER evaluation.